Mirjam Boelens to Mutation
This is a "connection" page, showing publications Mirjam Boelens has written about Mutation.
Connection Strength
0.186
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
Score: 0.102
-
Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid. Oncogene. 2024 Jun; 43(24):1877-1882.
Score: 0.024
-
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF? J Neurooncol. 2023 Mar; 162(1):1-13.
Score: 0.022
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.019
-
The force of HER2 - A druggable target in NSCLC? Cancer Treat Rev. 2020 Jun; 86:101996.
Score: 0.018